IBSERNIS Trademark

Trademark Overview

On Friday, September 27, 2013, a trademark application was filed for IBSERNIS with the United States Patent and Trademark Office. The USPTO has given the IBSERNIS trademark a serial number of 86076945. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2017. This trademark is owned by Glaxo Group Limited. The IBSERNIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ibsernis

General Information

Serial Number86076945
Word MarkIBSERNIS
Filing DateFriday, September 27, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, April 10, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 10, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 26, 2016EXTENSION 5 GRANTED
Monday, August 15, 2016EXTENSION 5 FILED
Monday, August 15, 2016TEAS EXTENSION RECEIVED
Friday, April 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 7, 2016EXTENSION 4 GRANTED
Thursday, March 3, 2016EXTENSION 4 FILED
Wednesday, April 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2016TEAS EXTENSION RECEIVED
Thursday, September 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2015EXTENSION 3 GRANTED
Thursday, September 3, 2015EXTENSION 3 FILED
Tuesday, September 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 3, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2015EXTENSION 2 GRANTED
Monday, March 2, 2015EXTENSION 2 FILED
Tuesday, April 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Saturday, August 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 28, 2014EXTENSION 1 GRANTED
Thursday, August 28, 2014EXTENSION 1 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Tuesday, March 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 3, 2013ASSIGNED TO EXAMINER
Friday, October 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 1, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

ibsernis pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological